Where do atoms come from? A physicist explains.

A Florida shoe company called Syntilay is aiming to design a shoe in space by 2026, marking a quirky but potentially significant milestone in the growing off-Earth economy. It’s not just about footwear—this experiment could pave the way for manufacturing innovations in microgravity.

Editor’s Note: While designing a shoe in space might sound like a gimmick, it’s actually part of a bigger shift toward figuring out how industries can operate beyond Earth. If companies like Syntilay can prove that manufacturing in space is viable, it could open doors for more ambitious projects—maybe even factories on the Moon or Mars someday. Plus, it’s a fun reminder that the future of business isn’t just terrestrial anymore.

Scientists have uncovered a sneaky tactic some cancer cells use to fuel their growth and spread—they literally steal energy-producing mitochondria from nearby nerve cells. This biological heist could explain why certain cancers are so aggressive, and it opens up fresh possibilities for targeted treatments that could block this process.

Editor’s Note: This isn’t just another lab discovery—it’s a glimpse into how cunning cancers can be. If researchers can figure out how to stop tumors from hijacking mitochondria, it could lead to entirely new ways to slow or even prevent cancer’s spread. For patients, that’s a potential game-changer down the line.

Marvel just dropped the last trailer for Fantastic Four: First Steps, and fans are buzzing. The sneak peek gives us bigger glimpses of Galactus and Franklin Richards, but—despite some hopeful chants—Ben Grimm’s iconic "Clobberin’ Time" line is still MIA (for now). With just 30 days until release, the hype train is full speed ahead.

Editor’s Note: This isn’t just another trailer—it’s the final tease before one of Marvel’s most anticipated reboots hits theaters. The absence of "Clobberin’ Time" might sting for die-hards, but the bigger reveals (hello, planet-eating Galactus!) suggest the studio’s saving some fireworks for the big screen. For superhero fans, it’s time to mark calendars and dissect every frame.

The James Webb Space Telescope has just bagged its first exoplanet discovery—a Saturn-sized world still scorching hot from its birth. Dubbed a "shepherd" planet, it’s tucked inside a distant ring system 110 light-years away and holds the record as the lightest exoplanet Webb has spotted so far.

Editor’s Note: This isn’t just another exoplanet—it’s a milestone for the James Webb telescope, proving it can detect even relatively small, faint worlds. The fact that this planet is still glowing from its formation gives scientists a rare peek into how planets evolve. For space nerds, it’s a thrilling hint at the kind of discoveries Webb might unlock next.

Robert F. Kennedy Jr., a prominent vaccine skeptic, is calling out Gavi, the global vaccine alliance, for allegedly disregarding scientific evidence in its policies. He claims the organization is prioritizing other interests over transparent, data-driven decision-making—a charge Gavi has yet to respond to publicly.

Editor’s Note: Kennedy’s accusations add fuel to the already heated debate over vaccine trust and transparency. Whether you agree with him or not, his high-profile criticism forces a conversation about how global health organizations operate—and who holds them accountable. For everyday people, it’s another layer in the confusing, often polarized discussion about who to believe when it comes to vaccines.